Paul Frisch is currently an Associate Attending in the Department of Medical Physics and the Chief of Biomedical Engineering at Memorial Sloan-Kettering Cancer Center. He currently serves on technical committees and advisory boards including IEEE Counsel on RFID, ECRI Institute and serves as the Chief Technical Officer for the RFID in Healthcare Consortium and President of the Intelligent Health Association. Paul’s responsibility focuses on the investigation of new and evolving technologies and developing their potential integration into clinical applications and operations to enhance patient outcomes, care, and safety. Current areas of investigation focus on clinical 3D imaging and printing, robotics, and medical device development.Previous experiences include research in electromagnetic field induced gene expression in targeted gene therapy, human biodynamics resulting from transitory acceleration, such as crash-impact and aircraft ejection and robotic applications in pharmaceutical development.Paul Frisch has a Doctoral degree in Biomedical Engineering from the State University of New York at Binghamton and Masters and Bachelors degrees in Electrical Engineering from the State University of New York at Stony Brook. He is the co-author of the forthcoming Routledge title, Leveraging Technology as a Response to the COVID 19 Pandemic.

• Section I: Enabling Hospital Intelligence Section 2: Technology Enabled Workflows Across the Environment of Care Section 3: Engineering & Technology Development Patient Specific Solutions Section 4: Technology Management Within the Intelligent Hospital Appendix 1: Policies & Procedures Appendix 2: Medical Systems – Device Inventory Management Appendix 3: Glossary of Terms

Paul Frisch is currently an Associate Attending in the Department of Medical Physics and the Chief of Biomedical Engineering at Memorial Sloan-Kettering Cancer Center. He currently serves on technical committees and advisory boards including IEEE Counsel on RFID, ECRI Institute and serves as the Chief Technical Officer for the RFID in Healthcare Consortium and President of the Intelligent Health Association. Paul’s responsibility focuses on the investigation of new and evolving technologies and developing their potential integration into clinical applications and operations to enhance patient outcomes, care, and safety. Current areas of investigation focus on clinical 3D imaging and printing, robotics, and medical device development.Previous experiences include research in electromagnetic field induced gene expression in targeted gene therapy, human biodynamics resulting from transitory acceleration, such as crash-impact and aircraft ejection and robotic applications in pharmaceutical development.Paul Frisch has a Doctoral degree in Biomedical Engineering from the State University of New York at Binghamton and Masters and Bachelors degrees in Electrical Engineering from the State University of New York at Stony Brook. He is the co-author of the forthcoming Routledge title, Leveraging Technology as a Response to the COVID 19 Pandemic.

• Section I: Enabling Hospital Intelligence Section 2: Technology Enabled Workflows Across the Environment of Care Section 3: Engineering & Technology Development Patient Specific Solutions Section 4: Technology Management Within the Intelligent Hospital Appendix 1: Policies & Procedures Appendix 2: Medical Systems – Device Inventory Management Appendix 3: Glossary of Terms

Paul Frisch is currently an Associate Attending in the Department of Medical Physics and the Chief of Biomedical Engineering at Memorial Sloan-Kettering Cancer Center. He currently serves on technical committees and advisory boards including IEEE Counsel on RFID, ECRI Institute and serves as the Chief Technical Officer for the RFID in Healthcare Consortium and President of the Intelligent Health Association. Paul’s responsibility focuses on the investigation of new and evolving technologies and developing their potential integration into clinical applications and operations to enhance patient outcomes, care, and safety. Current areas of investigation focus on clinical 3D imaging and printing, robotics, and medical device development.Previous experiences include research in electromagnetic field induced gene expression in targeted gene therapy, human biodynamics resulting from transitory acceleration, such as crash-impact and aircraft ejection and robotic applications in pharmaceutical development.Paul Frisch has a Doctoral degree in Biomedical Engineering from the State University of New York at Binghamton and Masters and Bachelors degrees in Electrical Engineering from the State University of New York at Stony Brook. He is the co-author of the forthcoming Routledge title, Leveraging Technology as a Response to the COVID 19 Pandemic.

• Section I: Enabling Hospital Intelligence Section 2: Technology Enabled Workflows Across the Environment of Care Section 3: Engineering & Technology Development Patient Specific Solutions Section 4: Technology Management Within the Intelligent Hospital Appendix 1: Policies & Procedures Appendix 2: Medical Systems – Device Inventory Management Appendix 3: Glossary of Terms